You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial
|
---|---|
Published in |
The Lancet, May 2018
|
DOI | 10.1016/s0140-6736(18)31033-x |
Pubmed ID | |
Authors |
Nikola Sprigg, Katie Flaherty, Jason P Appleton, Rustam Al-Shahi Salman, Daniel Bereczki, Maia Beridze, Hanne Christensen, Alfonso Ciccone, Ronan Collins, Anna Czlonkowska, Robert A Dineen, Lelia Duley, Juan Jose Egea-Guerrero, Timothy J England, Kailash Krishnan, Ann Charlotte Laska, Zhe Kang Law, Serefnur Ozturk, Stuart J Pocock, Ian Roberts, Thompson G Robinson, Christine Roffe, David Seiffge, Polly Scutt, Jegan Thanabalan, David Werring, David Whynes, Philip M Bath, TICH-2 Investigators |
X Demographics
The data shown below were collected from the profiles of 311 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 65 | 21% |
United States | 25 | 8% |
Canada | 18 | 6% |
Australia | 12 | 4% |
Japan | 9 | 3% |
Spain | 9 | 3% |
Mexico | 8 | 3% |
Colombia | 6 | 2% |
Turkey | 5 | 2% |
Other | 56 | 18% |
Unknown | 98 | 32% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 202 | 65% |
Practitioners (doctors, other healthcare professionals) | 68 | 22% |
Scientists | 31 | 10% |
Science communicators (journalists, bloggers, editors) | 10 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 510 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 510 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 71 | 14% |
Researcher | 57 | 11% |
Student > Doctoral Student | 43 | 8% |
Student > Postgraduate | 36 | 7% |
Student > Bachelor | 34 | 7% |
Other | 122 | 24% |
Unknown | 147 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 219 | 43% |
Neuroscience | 34 | 7% |
Nursing and Health Professions | 18 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 2% |
Psychology | 7 | 1% |
Other | 43 | 8% |
Unknown | 177 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 465. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2023.
All research outputs
#59,359
of 25,837,817 outputs
Outputs from The Lancet
#1,022
of 43,003 outputs
Outputs of similar age
#1,337
of 344,945 outputs
Outputs of similar age from The Lancet
#22
of 370 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,003 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,945 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 370 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.